0
Signin
countryflagUS

18889881171

AAPL 169.89 0.5147% MSFT 399.04 -2.4495% GOOG 157.95 -1.9553% GOOGL 156.0 -1.9669% AMZN 173.67 -1.6535% NVDA 826.32 3.7087% META 441.38 -10.5613% TSLA 170.18 4.9652% TSM 136.58 2.7149% LLY 724.87 -1.0011% V 275.16 0.0509% AVGO 1294.42 2.9917% JPM 193.37 0.1502% UNH 493.86 1.3462% NVO 125.79 -0.2933% WMT 60.21 0.5679% LVMUY 167.91 -2.1618% XOM 121.35 0.2478% LVMHF 837.0 -2.6461% MA 462.11 -0.0843%

Aurora Cannabis Inc

Healthcare US ACB

6.71USD
-0.49(6.81%)

Last update at 2024-04-25T20:06:00Z

Day Range

6.717.11
LowHigh

52 Week Range

0.411.21
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-06-30 2021-06-30 2020-06-30 2019-06-30 2018-06-30
Type yearly yearly yearly yearly yearly
Date 2022-06-30 2021-06-30 2020-06-30 2019-06-30 2018-06-30
Income before tax -1720.12000M -699.79800M -3383.89600M -328.23100M 77.33M
Minority interest 0.35M 1.46M -24.35600M 4.41M 4.56M
Net income -1717.62400M -693.62500M -3310.33700M -290.83700M 71.94M
Selling general administrative 126.97M 139.68M 265.18M 279.40M 80.42M
Selling and marketing expenses 62.02M 55.20M 91.27M 99.29M 29.45M
Gross profit 21.23M -21.55800M -33.53900M 159.81M 43.52M
Reconciled depreciation 93.66M 98.08M 114.89M 88.26M 12.26M
Ebit -236.74900M -235.27600M -508.12200M -302.92100M -90.71600M
Ebitda -143.08900M -137.20000M -393.23100M -214.66200M -78.45600M
Depreciation and amortization 93.66M 98.08M 114.89M 88.26M 12.26M
Non operating income net other - - - 0.00000M 0.00000M
Operating income -231.44900M -282.81800M -490.96200M -314.24400M -95.77200M
Other operating expenses 440.71M 491.90M 763.38M 544.97M 135.30M
Interest expense 71.81M 66.44M 77.54M 41.02M 2.28M
Tax provision -2.14100M -6.32100M -83.40300M -29.90900M 8.10M
Interest income 4.51M 5.75M 56.59M 70.89M 190.42M
Net interest income -67.30600M -60.69200M -72.54800M -37.34600M -10.64800M
Extraordinary items - - -9.84400M 0.14M 0.00000M
Non recurring - - - 0.00000M 0.00000M
Other items - - - 0.00000M 0.00000M
Income tax expense -2.14100M -6.32100M -83.40300M -30.30700M 8.10M
Total revenue 221.34M 245.25M 278.91M 247.94M 55.20M
Total operating expenses 240.60M 225.09M 450.93M 456.84M 123.63M
Cost of revenue 200.11M 266.81M 312.44M 88.12M 11.68M
Total other income expense net -1433.43900M -392.46100M -2826.87900M 6.14M 168.08M
Discontinued operations - -1.61200M -9.84400M 0.14M 0.14M
Net income from continuing ops -1717.97900M -693.47700M -3300.49300M -297.92400M 69.23M
Net income applicable to common shares -1717.62400M -693.62500M -3283.67100M -293.50900M 71.94M
Preferred stock and other adjustments - - - 0.00000M 0.00000M
Breakdown 2022-06-30 2021-06-30 2020-06-30 2019-06-30 2018-06-30
Type yearly yearly yearly yearly yearly
Date 2022-06-30 2021-06-30 2020-06-30 2019-06-30 2018-06-30
Total assets 1084.36M 2604.73M 2783.70M 5502.83M 1910.72M
Intangible assets 70.70M 367.45M 412.27M 688.37M 256.23M
Earning assets - - - - -
Other current assets 6.54M 11.17M 22.14M 51.84M 13.62M
Total liab 422.00M 567.03M 657.25M 1112.78M 347.58M
Total stockholder equity 661.84M 2037.70M 2150.81M 4385.64M 1558.57M
Deferred long term liab - - - 0.00000M 0.00000M
Other current liab 94.52M 57.99M 21.09M 146.55M 22.99M
Common stock 6754.63M 6424.30M 5785.40M 4673.12M 1466.43M
Capital stock 6754.63M 6424.30M 5785.40M 4673.12M -
Retained earnings -6038.27500M -4321.08500M -3592.78700M -283.63800M 87.75M
Other liab 40.29M 92.04M 5.81M 280.34M 57.66M
Good will 0.00000M 887.74M 928.43M 3172.55M 729.05M
Other assets 33.87M 77.27M 57.76M 93.33M 124.94M
Cash 437.81M 421.46M 162.18M 172.73M 89.19M
Cash and equivalents - - - - -
Total current liabilities 145.23M 116.38M 272.81M 436.37M 75.17M
Current deferred revenue 3.85M 4.17M 3.52M 1.48M 2.27M
Net debt -168.31600M -21.90700M 369.07M 472.10M 114.02M
Short term debt 33.00M 40.94M 152.62M 249.67M 2.45M
Short long term debt 26.85M 34.75M 152.62M 249.67M 2.45M
Short long term debt total 269.49M 399.55M 531.25M 644.83M 203.21M
Other stockholder equity -54.50800M -65.51100M 73.84M -3.84300M 59.23M
Property plant equipment 230.30M 598.28M 928.23M 750.08M 242.86M
Total current assets 745.12M 665.89M 420.74M 664.17M 219.70M
Long term investments 1.21M 0.29M 18.11M 118.84M 334.44M
Net tangible assets 587.99M 774.70M 791.96M 506.56M 583.79M
Short term investments 1.33M 3.75M 7.07M 143.25M 60.18M
Net receivables 47.05M 56.48M 54.11M 112.33M 15.10M
Long term debt 199.65M 293.18M 294.93M 394.19M 200.76M
Inventory 139.93M 137.72M 157.26M 165.48M 43.22M
Accounts payable 13.86M 13.28M 95.57M 38.67M 47.46M
Total permanent equity - - - 0.00000M 0.00000M
Noncontrolling interest in consolidated entity - - - 0.00000M 0.00000M
Temporary equity redeemable noncontrolling interests - - - 0.00000M 0.00000M
Accumulated other comprehensive income -54.50800M -65.51100M -41.80200M -3.84300M 4.39M
Additional paid in capital - - - 0.00000M 0.00000M
Common stock total equity - 6424.30M 5785.40M 4673.12M 1466.43M
Preferred stock total equity - - - 0.00000M 0.00000M
Retained earnings total equity - - - 0.00000M 0.00000M
Treasury stock - - - 0.00000M 0.00000M
Accumulated amortization - - - 0.00000M 0.00000M
Non currrent assets other 33.87M 77.27M 57.76M 93.33M 124.94M
Deferred long term asset charges - - - 0.00000M 0.00000M
Non current assets total 339.24M 1938.84M 2362.96M 4838.66M 1691.02M
Capital lease obligations 42.99M 71.62M - 0.00000M 0.00000M
Long term debt total - - 378.63M 395.16M 200.76M
Breakdown 2022-06-30 2021-06-30 2020-06-30 2019-06-30 2018-06-30
Type yearly yearly yearly yearly yearly
Date 2022-06-30 2021-06-30 2020-06-30 2019-06-30 2018-06-30
Investments -36.60000M 18.06M -249.48300M -312.29700M -537.75900M
Change to liabilities 3.31M -28.08000M -19.34300M 98.98M 2.53M
Total cashflows from investing activities -36.60000M -26.90500M -249.48300M -312.29700M -536.85000M
Net borrowings -170.83100M -122.92000M -38.83000M 583.74M 344.82M
Total cash from financing activities 147.78M 521.95M 582.56M 597.55M 548.55M
Change to operating activities 6.47M 12.64M -2.45200M -11.02900M -14.70600M
Net income -1717.97900M -693.47700M -3300.49300M -297.92400M 69.23M
Change in cash 16.35M 259.28M -10.54800M 95.94M -70.52200M
Begin period cash flow 421.46M 162.18M 172.73M 76.78M 159.72M
End period cash flow 437.81M 421.46M 162.18M 172.73M 89.19M
Total cash from operating activities -109.83800M -210.57700M -337.95200M -192.24500M -81.66700M
Issuance of capital stock 350.19M 666.03M 575.51M 59.33M -
Depreciation 93.66M 98.08M 114.89M 88.26M 12.26M
Other cashflows from investing activities -0.18500M -4.67500M -9.30300M -5.56100M -5.56100M
Dividends paid - - - 0.00000M 0.00000M
Change to inventory 21.07M 8.45M -29.39000M -50.28400M -10.43700M
Change to account receivables 18.76M 7.37M 55.46M -57.16100M -5.88700M
Sale purchase of stock - - 575.51M 59.33M 215.61M
Other cashflows from financing activities -31.57800M -21.15200M 132.28M 559.58M 333.22M
Change to netincome 1464.18M 384.57M 2823.18M 50.29M -140.47100M
Capital expenditures 32.21M 53.08M 355.01M 414.30M 136.94M
Change receivables - - - 0.00000M 0.00000M
Cash flows other operating - - - 0.00000M 0.00000M
Exchange rate changes - - - 0.00000M 0.00000M
Cash and cash equivalents changes - - - 0.00000M 0.00000M
Change in working capital 49.95M 0.40M 7.64M -37.95200M -25.39200M
Stock based compensation 13.76M 20.24M 59.90M 107.04M 37.45M
Other non cash items 1452.97M 370.63M 2858.41M -28.41000M -181.65300M
Free cash flow -142.05100M -263.65900M -692.95800M -606.54300M -218.61200M

Fundamentals

  • Previous Close 7.20
  • Market Cap237.52M
  • Volume4230950
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-143.76000M
  • Revenue TTM225.18M
  • Revenue Per Share TTM0.74
  • Gross Profit TTM 21.23M
  • Diluted EPS TTM-5.96

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ACB
Aurora Cannabis Inc		 -0.49 6.81% 6.71 - - 1.00 0.59 1.05 -0.1362
ZTS
Zoetis Inc		 2.48 1.64% 153.36 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 -0.37 1.14% 32.07 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 6.97 4.40% 165.33 21.73 14.95 3.16 2.15 3.56 12.82
TAK
Takeda Pharmaceutical Co Ltd ADR		 -0.16 1.21% 13.07 32.67 11.53 0.01 0.87 0.02 0.07

Reports Covered

Stock Research & News

View All

Profile

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Aurora Cannabis Inc

500 - 10355 Jasper Avenue, Edmonton, AB, Canada, T5J 1Y6

Key Executives

Name Title Year Born
Mr. Miguel Martin CEO & Director 1972
Mr. Glen Ibbott Chief Financial Officer NA
Mr. Alex Miller Exec. VP of Operations & Supply Chain NA
Ms. Lori Schick Exec. VP of HR NA
Mr. Andre Jerome Exec. VP of Global Bus. Devel. NA
Ananth Krishnan VP of Capital Markets & Investor Relations NA
Mr. Nathalie Clark Exec. VP, Gen. Counsel & Corp. Sec. NA
Michelle Lefler VP of Communications & PR NA
Mr. Carey Squires Exec. VP of Corp. Devel. & Strategy NA
Mr. John Barnet Chief Cultivator NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).